Transposable Elements and Genome Regulation

Transposable elements (TEs) are discrete DNA sequences capable of moving within and between genomes, shaping genome architecture and function across all domains of life. They encompass two principal classes: DNA transposons, which mobilise via a “cut-and-paste” mechanism, and retrotransposons, which replicate through an RNA intermediate before reintegration. Together they account for a substantial fraction of many eukaryotic genomes and have contributed to gene and regulatory innovation through insertional mutagenesis, exon shuffling and the provision of novel promoters or enhancers. Host genomes have evolved sophisticated regulatory networks to restrain TE activity, relying on epigenetic silencing mechanisms—such as DNA methylation and repressive histone modifications—and small RNA pathways exemplified by Piwi-interacting RNAs (piRNAs). Beyond repression, TEs have been exapted as sources of cis-regulatory modules and long noncoding RNAs, influencing tissue-specific gene expression and developmental programmes. Dysregulation of TE mobilisation has been implicated in genome instability, ageing, cancer and autoimmune disorders, whereas controlled TE activity can drive genomic diversity and adaptive responses. Advances in structural biology, population genomics and single-cell technologies are now elucidating the interplay between TE machineries and host defence systems, offering new perspectives on TE-mediated evolution, disease mechanisms and potential therapeutic interventions.

Research from Nature Portfolio

Recent studies have resolved high-resolution structures of the human L1 open reading frame 2 protein (ORF2p), revealing previously unrecognised domains that coordinate reverse transcriptase and endonuclease activities during retrotransposition. Integrative models depict dynamic conformational changes that enable target-primed reverse transcription and suggest avenues for selective inhibition of ORF2p as a therapeutic strategy in diseases associated with aberrant L1 activity. In parallel, pan-cancer analyses have uncovered widespread somatic L1 insertions in multiple tumour types, demonstrating that L1 integration can drive megabase-scale chromosomal rearrangements, deletion of tumour suppressor loci and oncogene amplification through breakage–fusion–bridge cycles. These findings underscore the dual role of L1 as both a mutagenic agent in carcinogenesis and a potential biomarker for genome instability in clinical oncology.

Research from all publishers

Emerging work in immunology has highlighted the paradoxical roles of endogenous retroelements in host defence and pathology. When epigenetic repression falters, retroelements can elicit innate and adaptive immune responses that contribute to autoinflammatory and age-related disorders, yet regulated immune recognition of TE-derived nucleic acids is also essential for immune system development and cancer immunosurveillance. Complementary reviews of host restriction factors detail cellular strategies to coexist with retrotransposons, including RNA-degrading enzymes, cytoplasmic sensors and nuclear DNA repair proteins, as well as the piRNA pathway in germ cells. These mechanisms collectively maintain genome integrity while permitting controlled TE expression in specific contexts, such as neuronal plasticity and stem cell differentiation.

Transposable Elements and Genome Regulation publication trend

The graph below shows the total number of articles in transposable elements and genome regulation across all publications each year (not limited to Nature Index journals).

Technical terms

Transposable element: A DNA sequence that can change its position within a genome, potentially altering gene function and genome structure.

Retrotransposon: A class of transposable element that mobilises via an RNA intermediate and a reverse transcription step before reintegration.

DNA transposon: A transposable element that moves through excision from one genomic locus and insertion into another without an RNA intermediate.

piRNA: A class of small noncoding RNAs that associate with Piwi proteins to mediate sequence-specific silencing of transposable elements, predominantly in germ cells.

Epigenetic silencing: Repression of gene or element activity through heritable chromatin modifications, such as DNA methylation and histone methylation.

LINE-1 (L1): The only autonomous non-LTR retrotransposon currently active in the human genome, encoding proteins essential for its own mobilisation.

References

1. Structures, functions and adaptations of the human LINE-1 ORF2 protein. Nature (2023).
2. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nature Genetics (2020).
3. The Immunological Conundrum of Endogenous Retroelements. Annual Review of Immunology (2023).
4. Roles for retrotransposon insertions in human disease. Mobile DNA (2016).
5. Repetitive Elements May Comprise Over Two-Thirds of the Human Genome. PLOS Genetics (2011).
6. Transposable Elements Are Major Contributors to the Origin, Diversification, and Regulation of Vertebrate Long Noncoding RNAs. PLOS Genetics (2013).
7. Restricting retrotransposons: a review. Mobile DNA (2016).